Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY – Get Free Report)’s stock price dropped 4.3% during trading on Tuesday. The company traded as low as $10.5750 and last traded at $10.5750. Approximately 205 shares traded hands during trading, a decline of 98% from the average daily volume of 9,080 shares. The stock had previously closed at $11.05.
Santen Pharmaceutical Stock Performance
The company has a 50-day moving average of $11.63 and a 200-day moving average of $11.74.
About Santen Pharmaceutical
Santen Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company focused on ophthalmology. The company researches, develops, manufactures and markets prescription ophthalmic medicines and related products used to treat eye diseases and disorders.
Its product portfolio addresses conditions including glaucoma, dry eye disease, retinal diseases, ocular allergies, infections and inflammation. Santen also develops treatments for other serious vision-related conditions and provides products for eye-care professionals and patients.
Founded in 1890 and headquartered in Osaka, Japan, Santen has built a business serving patients and healthcare providers in Japan and international markets, including other parts of Asia, Europe and North America.
See Also
- Five stocks we like better than Santen Pharmaceutical
- Boeing’s Fighter Victory Opens the Door to Decades of Defense Revenue
- Deutsche Bank Makes a Contrarian Call on Netflix—What Does It Mean for Investors?
- O’Reilly Automotive’s Stock Slump Hides a Stronger Business
- McDonald’s Stock Slump Makes Its AI Pricing Bet Even Riskier
Receive News & Ratings for Santen Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Santen Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
